Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial
Published 2006 · A. Durazzo, F. Machado, D. Ikeoka
Journal of Vascular Surgery
387
Citations
3
Influential Citations
Abstract
Abstract removed due to Elsevier request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Key takeawayShort-term treatment with atorvastatin significantly reduces the incidence of major adverse cardiovascular events compared to placebo within 6 months after vascular surgery.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.